Key terms
About NVO
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest NVO news
May 28
8:29pm ET
ProKidney price target raised to $4 from $3 at BofA
May 28
8:39am ET
Novo Nordisk Launches Major Share Buyback
May 27
7:25am ET
Buy Rating Affirmed for Novo Nordisk on Strong Clinical Data and Competitive Edge in Metabolic Disease Treatment
May 21
5:23pm ET
58% of Novo Nordisk’s (NYSE:NVO) Saxenda and Wegovy Users Quit Early
May 20
11:21am ET
Hims & Hers soars after announcing $199 weight loss shots
May 20
9:52am ET
Genetic Profile Predicts Success with Novo Nordisk’s (NYSE:NVO) Wegovy
May 17
5:29pm ET
Novo Nordisk Launches Significant Share Buyback
May 15
5:55pm ET
Soros buys Okta, cuts Amazon in Q1
May 15
9:58am ET
Novo Nordisk Executive Reports Share Sale
May 14
7:26am ET
TD Cowen Reaffirms Their Buy Rating on Novo Nordisk (NVO)
May 14
7:16am ET
Buy Rating Affirmed for Novo Nordisk: Strong Performance and Promising Pipeline Underpin Positive Outlook
May 13
1:58pm ET
Novo Nordisk mim8 data near Jefferies’ ‘best’ case scenario
May 13
1:57pm ET
Novo Nordisk Revolutionizes Haemophilia A Treatment
May 13
11:55am ET
Novo Nordisk reports FRONTIER 2 trial achieved co-primary endpoints
May 13
9:36am ET
Novo Nordisk (NVO) Gets a Buy from Bank of America Securities
May 13
7:28am ET
Novo Nordisk Executive Gift Shares Report
May 09
7:14am ET
Flagship Pioneering, Metaphore announce research collab with Novo Nordisk
May 08
6:32am ET
Drugmakers work to make treatments to maintain weight loss, WSJ reports
May 06
5:57pm ET
Novo Nordisk Executes Major Share Buyback
May 06
5:57pm ET
Novo Nordisk Launches New Share Buyback Plan
May 06
5:57pm ET
Novo Nordisk Executives Trade Company Shares
May 06
2:44pm ET
Novo Nordisk purchases B shares worth DKK 5.428B from Novo Holdings A/S
May 06
6:57am ET
Novo Nordisk Executives Engage in Share Sales
May 03
11:13am ET
Amgen price target raised to $325 from $315 at BofA
May 02
9:40am ET
Unusually active option classes on open May 2nd
May 02
8:29am ET
Novo Nordisk Q1 Sales and Profit Surge
May 02
7:49am ET
Novo Nordisk reports Q1 EPS DKK 5.68 vs. DKK 4.39 last year
May 02
7:36am ET
Buy Rating Affirmed for Novo Nordisk on Strong Product Performance and Market Position
May 02
6:56am ET
NVO Earnings: Novo Nordisk Drops Despite Hiked Financial Outlook
May 02
6:23am ET
Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO), Sarepta Therapeutics (SRPT) and Acadia Healthcare (ACHC)
May 01
9:47am ET
Novo Nordisk Completes Share Buyback
No recent press releases are available for NVO
NVO Financials
Key terms
Ad Feedback
NVO Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
NVO Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
